Drug
Mk0767
Mk0767: highest development phase Phase 3, developed by Merck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| MK0767 NCT00543751 | Phase 3 | Diabetes Mellitus, Type 2 |
| MK0767 NCT00543361 | Phase 3 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Mk0767 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.